首页> 外文期刊>Breast Cancer Research and Treatment >Development of a novel method for measuring in vivo breast epithelial cell proliferation in humans
【24h】

Development of a novel method for measuring in vivo breast epithelial cell proliferation in humans

机译:测量人体体内乳腺上皮细胞增殖的新方法的发展

获取原文
获取原文并翻译 | 示例
           

摘要

Cell proliferation plays an important role in all stages of carcinogenesis. Currently, no safe, direct, in vivo method of measuring breast epithelial cell (BEC) proliferation rates in humans exists. Static immunohistochemical markers of cell proliferation, such as Ki-67 and PCNA indices, have technical limitations including high inter-lab variability, inaccuracy in the presence of agents that cause G1/S cell cycle block and inadequate sensitivity in post-menopausal women with low BEC proliferation rates. We describe here a safe, direct method of measuring BEC proliferation rates in vivo in women using heavy water (2H2O) labeling coupled with mass spectrometric analysis. Proliferation of normal and tumor BEC was measured from breast tissue biopsies in women undergoing mastectomy (n=11) and normal BEC from healthy volunteers (n=16). Women took heavy water (50–150 ml per day) for 1–4 weeks. Pre-menopausal women had significantly higher proliferation rates than post-menopausal women (0.7 ± 0.1 versus 0.2 ± 0.1 new cells per day, respectively), and tumor BEC had different proliferation rates than normal BEC from the same breast. The method is analytically reproducible and remains sensitive in the range of low proliferation rates. In summary, this novel method of measuring BEC proliferation in vivo holds promise for assessing the effects of anti-proliferative chemopreventive and chemotherapeutic agents.
机译:细胞增殖在癌变的所有阶段均起重要作用。当前,不存在测量人乳腺上皮细胞(BEC)增殖速率的安全,直接,体内的方法。细胞增殖的静态免疫组织化学标记物(例如Ki-67和PC​​NA指数)具有技术局限性,包括实验室间变异性高,存在导致G1 / S细胞周期阻滞的药物时不准确以及绝经后低发女性的敏感性不足BEC扩散率。我们在这里描述一种安全,直接的方法,该方法使用重水(2 H2 O)标记结合质谱分析来测量女性体内BEC增殖率。从接受乳房切除术的妇女的乳房组织活检(n = 11)和健康志愿者的正常BEC(n = 16)中测量正常和肿瘤BEC的增殖。妇女服用重水(每天50-150毫升)持续1-4周。绝经前妇女的增殖率明显高于绝经后妇女(分别为每天0.7±0.1对0.2±0.1新细胞),并且同一乳房的肿瘤BEC的增殖率与正常BEC不同。该方法在分析上可重现,并且在低增殖率范围内仍然敏感。总而言之,这种测量体内BEC增殖的新方法有望用于评估抗增殖化学预防药和化学治疗药的效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号